1. Home
  2. OVID vs MNSB Comparison

OVID vs MNSB Comparison

Compare OVID & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • MNSB
  • Stock Information
  • Founded
  • OVID 2014
  • MNSB 2003
  • Country
  • OVID United States
  • MNSB United States
  • Employees
  • OVID N/A
  • MNSB N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • MNSB Major Banks
  • Sector
  • OVID Health Care
  • MNSB Finance
  • Exchange
  • OVID Nasdaq
  • MNSB Nasdaq
  • Market Cap
  • OVID 117.3M
  • MNSB 140.1M
  • IPO Year
  • OVID 2017
  • MNSB N/A
  • Fundamental
  • Price
  • OVID $1.34
  • MNSB $18.44
  • Analyst Decision
  • OVID Strong Buy
  • MNSB
  • Analyst Count
  • OVID 4
  • MNSB 0
  • Target Price
  • OVID $3.13
  • MNSB N/A
  • AVG Volume (30 Days)
  • OVID 1.5M
  • MNSB 41.9K
  • Earning Date
  • OVID 11-12-2025
  • MNSB 10-27-2025
  • Dividend Yield
  • OVID N/A
  • MNSB 2.14%
  • EPS Growth
  • OVID N/A
  • MNSB N/A
  • EPS
  • OVID N/A
  • MNSB N/A
  • Revenue
  • OVID $6,610,000.00
  • MNSB $69,367,000.00
  • Revenue This Year
  • OVID $1,081.80
  • MNSB $23.19
  • Revenue Next Year
  • OVID N/A
  • MNSB $2.92
  • P/E Ratio
  • OVID N/A
  • MNSB N/A
  • Revenue Growth
  • OVID 945.89
  • MNSB 9.71
  • 52 Week Low
  • OVID $0.24
  • MNSB $15.00
  • 52 Week High
  • OVID $2.01
  • MNSB $22.98
  • Technical
  • Relative Strength Index (RSI)
  • OVID 46.30
  • MNSB 48.32
  • Support Level
  • OVID $1.24
  • MNSB $17.86
  • Resistance Level
  • OVID $1.39
  • MNSB $18.53
  • Average True Range (ATR)
  • OVID 0.10
  • MNSB 0.42
  • MACD
  • OVID -0.02
  • MNSB 0.10
  • Stochastic Oscillator
  • OVID 45.94
  • MNSB 69.75

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

Share on Social Networks: